US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P 500 Equal Weight Health Care ETF

36.78

+0.07500.20%

Volume:177.68K

Turnover:6.54M

Market Cap:849.13M

PE:- -

High:37.05

Open:36.69

Low:36.66

Close:36.70

52wk High:38.19

52wk Low:28.26

Shares:23.09M

Float Shares:23.09M

Volume Ratio:1.91

T/O Rate:0.77%

Dividend:0.23

Dividend Rate:0.63%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Elevance Health (ELV) Raises 2026 Targets And Exits Weak Medicaid Markets

Simply Wall St.

Amneal receives FDA approval for additional iohexol strengths, presentations

Virax Biolabs Boosts Liquidity, Secures Fosun Deal and Restores Nasdaq Compliance After Fiscal 2026 Report

Shanghai Launches Pilot for Streamlined Import of Medical Device Production Materials

Elevance Health Stock Weakness Despite Q2 Beat Reflects Medicaid Utilization Pressure, RBC Capital Markets Says

MT Newswires Live

Chison Medical's Self-Developed Breast AI Ultrasound Robot Secures Pioneering Medical Device Test Report

HCA preannouncement negative for Quest, Labcorp, says Barclays

Elevance Beat Earnings Estimates, but the Stock Falls on Medicaid Spending Worries

Elevance Plans to Exit More Medicaid Markets

Elevance Stock Falls on Medicaid Concerns

Johnson & Johnson: Expiration of ACA subsidies won’t impact procedure demand

iX Biopharma Warrants See Strong Insider Take-Up, Funding U.S. Expansion

Celcuity announces FDA approval of Revtorpyk

HCA Says Florida Medicaid Approval Cushions 2Q

Caris Life Sciences expands prostate cancer offering with PTEN IHC testing

Shanxi's Shuozhou City Enhances Safety Oversight of Cold Chain Medical Equipment

Nexalis Therapeutics Options Expire Unexercised, Streamlining Capital Structure

Nexalis Therapeutics Issues Over 4.1 Million Unquoted Performance Rights

Aroa Biosurgery Welcomes CMS Plan to Keep Outpatient Skin Substitute Rates

BioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/RSPH/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RSPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","market":"US","secType":"STK","nameCN":"Invesco S&P 500 Equal Weight Health Care ETF","latestPrice":36.775,"timestamp":1789588800000,"preClose":36.7,"halted":0,"volume":177678,"delay":0,"changeRate":0.002043596730245115,"floatShares":23090000,"shares":23090000,"eps":0,"marketStatus":"Pre-Mkt","change":0.075,"latestTime":"09-17 06:17:05 EDT","open":36.69,"high":37.05,"low":36.66,"amount":6543534.267899999,"amplitude":0.010627,"askPrice":44.5,"askSize":100,"bidPrice":14.79,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":36.775,"sharesOutstanding":23410000,"nav":36.6802,"aum":849146630,"dividendRate":0.006279,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":36.775,"preClose":36.775,"latestTime":"19:30 EDT","volume":16,"amount":588.355,"timestamp":1789601405974,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.9058314747695424,"impliedVol":0.0046,"impliedVolPercentile":0.016},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","floatShares":23090000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.9058314747695424,"shares":23090000,"dividePrice":0.2309,"high":37.05,"amplitude":0.010627,"preClose":36.7,"low":36.66,"week52Low":28.26,"pbRate":"--","week52High":38.19,"institutionHeld":0,"latestPrice":36.775,"eps":0,"divideRate":0.006279,"volume":177678,"delay":0,"ttmEps":0,"open":36.69,"prevYearClose":31.85,"prevWeekClose":36.08,"prevMonthClose":37.4,"prevQuarterClose":33.19,"fiveDayClose":36.3,"twentyDayClose":36,"sixtyDayClose":31.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RSPH\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"RSPH","amount":0.06267,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"RSPH","amount":0.05609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"RSPH","amount":0.05305,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"RSPH","amount":0.05991,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"RSPH","amount":0.05546,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RSPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.174967,"currency":"USD"},{"executeDate":"2023-06-20","recordDate":"2023-06-21","paymentDate":"2023-06-23","value":0.51083,"currency":"USD"},{"executeDate":"2023-09-18","recordDate":"2023-09-19","paymentDate":"2023-09-22","value":0.04794,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.04988,"currency":"USD"},{"executeDate":"2024-03-18","recordDate":"2024-03-19","paymentDate":"2024-03-22","value":0.04585,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RSPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RSPH\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652258542","title":"Elevance Health (ELV) Raises 2026 Targets And Exits Weak Medicaid Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2652258542","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652258542?lang=en_us&edition=fundamental","pubTime":"2026-07-19 02:21","pubTimestamp":1784398891,"startTime":"0","endTime":"0","summary":"Elevance Health (NYSE:ELV) raised its 2026 EPS guidance and operating cash flow targets following its Q2 results.\nThe company plans to exit underperforming Medicaid markets while continuing to invest in medical cost management and AI-enabled capabilities.\nManagement highlighted that these moves are intended to address membership declines, margin pressures, and a large accrual tied to Medicare risk adjustments.\n\nElevance Health is a major US managed care and health benefits company, with a...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-raises-2026-targets-and-exits-weak-medic","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/elevance-health-elv-raises-2026-targets-and-exits-weak-medic","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7095","LU1023059063.AUD","LU0114720955.EUR","LU0980610538.SGD","LU2362541273.HKD","LU0289739699.SGD","LU0122379950.USD","LU0208291251.USD","LU0251131958.USD","LU2244417387.USD","LU2592432038.USD","LU0251142724.SGD","BK4588","ELV.AU","LU0058720904.USD","LU0130102774.USD","LU0225283273.USD","LU0557290698.USD","LU0878866978.SGD","LU0211331839.USD","ELV","SG9999004303.SGD","SG9999011175.SGD","LU1815333072.USD","LU2237957902.USD","LU0477156953.USD","LU0187121727.USD","LU0130517989.USD","IHF","LU2430703178.SGD","LU0742534661.SGD","RSPH","LU1280957306.USD","LU1548497426.USD","LU1670627923.USD","LU0345770993.USD","LU0314106906.USD","BK4154","LU1057294990.SGD","LU0070302665.USD","LU1670628061.USD","LU2430703251.USD","LU2505996681.GBP","LU1506573853.SGD","LU0345770308.USD","LU1983299246.USD","LU2108987350.USD","LU0882574055.USD","LU2362540622.SGD","LU1201861249.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652882192","title":"Amneal receives FDA approval for additional iohexol strengths, presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2652882192","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652882192?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:15","pubTimestamp":1784290509,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals (AMRX) announced that it has received FDA approval for additional strengths and vial presentations of iohexol injection, 350...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amneal-receives-fda-approval-for-additional-iohexol-strengths-presentations-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amneal-receives-fda-approval-for-additional-iohexol-strengths-presentations-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","MRNX","AMRX","PINK","BK4585","TECB","IYH","PSCH","BK4588","SYNB","BBP","BK4007","LABU","MEDI","RSPH","GDOC","MRNY","IBB","IDNA","BMED","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652409835","title":"Virax Biolabs Boosts Liquidity, Secures Fosun Deal and Restores Nasdaq Compliance After Fiscal 2026 Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2652409835","media":"TIPRANKS","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652409835?lang=en_us&edition=fundamental","pubTime":"2026-07-17 16:48","pubTimestamp":1784278109,"startTime":"0","endTime":"0","summary":"Virax Biolabs Group Ltd. Class A ( ($VRAX) ) has issued an announcement. Virax Biolabs Group Limited, a Nasdaq-listed biotechnology company focused...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/virax-biolabs-boosts-liquidity-secures-fosun-deal-and-restores-nasdaq-compliance-after-fiscal-2026-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/virax-biolabs-boosts-liquidity-secures-fosun-deal-and-restores-nasdaq-compliance-after-fiscal-2026-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BBP","IBB","LCLG","RSPH","SYNB","NQmain","XT","BK4585","FHLC","DARP","FWD","AGNG","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134717301","title":"Shanghai Launches Pilot for Streamlined Import of Medical Device Production Materials","url":"https://stock-news.laohu8.com/highlight/detail?id=1134717301","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134717301?lang=en_us&edition=fundamental","pubTime":"2026-07-16 23:41","pubTimestamp":1784216466,"startTime":"0","endTime":"0","summary":"Shanghai Customs and the Shanghai Municipal Science and Technology Commission have issued a joint announcement to initiate a pilot program for facilitating the import of production materials for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","MDEV","AGNG","BK1583","GDOC","HART","MEDX","PTH","BK1100","RSPH","159883","BK1574","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651442331","title":"Elevance Health Stock Weakness Despite Q2 Beat Reflects Medicaid Utilization Pressure, RBC Capital Markets Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2651442331","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651442331?lang=en_us&edition=fundamental","pubTime":"2026-07-16 23:03","pubTimestamp":1784214239,"startTime":"0","endTime":"0","summary":"Elevance Health  stock price decline despite a Q2 beat and upwardly revised full-year adjusted EPS guidance is primarily due to Medicaid utilization pressure among the continuing member base, RBC Capital Markets said in a research report emailed Thursday.Planned market exits over the next 18 months could also be cooling expectations around Medicaid recovery momentum, according to the note.The company's Q2 outperformance was partly driven by Medicare Advantage, alongside an $0.80 per share net benefit related to investment portfolio valuation adjustments, which it will redeploy into accelerated investments in H2, analysts wrote.The brokerage said it reiterated its sector perform rating on the stock and cut its price target to $424 per share from $439.Price: 376.68, Change: -13.66, Percent Change: -3.50","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237957811.SGD","ELV","LU0106261372.USD","LU0878866978.SGD","LU2505996509.AUD","LU2430703095.HKD","LU0289739699.SGD","LU0006306889.USD","LU0187121727.USD","LU0314106906.USD","LU0477156953.USD","LU2505996681.GBP","LU0980610538.SGD","LU1548497426.USD","LU1489326972.SGD","LU1023059063.AUD","LU1720051017.SGD","LU0640476718.USD","LU0882574055.USD","LU2244417387.USD","LU0320765489.SGD","ELV.AU","SG9999011175.SGD","LU1670627923.USD","LU0266013472.USD","GSIB","LU0058720904.USD","LU0128525929.USD","LU1720051108.HKD","LU2430703178.SGD","LU0029864427.USD","BK4154","LU2362540622.SGD","BK4585","LU2592432038.USD","LU0314104364.USD","LU2237957902.USD","LU0708994859.HKD","LU2430703251.USD","IHF","LU1983299246.USD","LU0048573561.USD","RSPH","BK4588","LU0070302665.USD","LU0345770308.USD","LU0234570918.USD","SG9999003800.SGD","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189914565","title":"Chison Medical's Self-Developed Breast AI Ultrasound Robot Secures Pioneering Medical Device Test Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1189914565","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189914565?lang=en_us&edition=fundamental","pubTime":"2026-07-16 22:01","pubTimestamp":1784210486,"startTime":"0","endTime":"0","summary":"On July 16th, Chison Medical Technologies Co.,Ltd. (ASX: 688358) responded to investor inquiries via an interactive platform, announcing that its independently developed \"Breast AI Ultrasound Robot\"...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QMAR","GK","NAPR","QQA","688358","QID","LCLG","QLD","BK1574","QSWN","02834","03455","BK1100","AGIX","03034","07522","QQQM","159883","BK0251","TARK","CHAT","ROBO","QTOC","NBDS","NJAN","MVPS","AIFD","09834","SQQQ","RSPH","QDEC","VUSE","ARTY","07568","09996","PTH","TQQQ","TQQY","MDEV","MEDX","07261","07266","AIBU","AGNG","GDOC","KOMP","QQQ","BK1583","CPNQ","NJUL","NOCT","PSQ","LGHT","HART","QQQX","BK4593","03086","FWD","NEWZ","OGIG","09086","161631","GPIQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651496887","title":"HCA preannouncement negative for Quest, Labcorp, says Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2651496887","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651496887?lang=en_us&edition=fundamental","pubTime":"2026-07-16 04:10","pubTimestamp":1784146228,"startTime":"0","endTime":"0","summary":"Barclays views HCA Healthcare’s (HCA) preannouncement on Affordable Care Act coverage lost during Q2 is a negative read-through for Quest Diagnosti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hca-preannouncement-negative-for-quest-labcorp-says-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hca-preannouncement-negative-for-quest-labcorp-says-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0708994859.HKD","LU0238689110.USD","CURE","LU0211328371.USD","LU0868494617.USD","LU0310799852.SGD","LU0320765489.SGD","SG9999014039.USD","LU2355687059.USD","RSPH","LU0211327993.USD","LABU","BK4581","LU0878866978.SGD","LU1093756168.USD","BK4185","LU0648001328.SGD","IE00B3S45H60.SGD","LU0128525929.USD","LU1150488218.USD","XBI","BK4504","LU1093756325.SGD","FHLC","LU0417517546.SGD","LU0203347892.USD","XHS","LU1983260115.SGD","XLV","LU0170899867.USD","BK4585","LU0208291251.USD","LU1119994496.HKD","FXH","IYH","IHF","LU0348723411.USD","HUM","LU0433182093.SGD","LU1267930490.SGD","LU1267930573.SGD","SG9999014005.SGD","LU0114720955.EUR","LU1261432733.SGD","LU1489326972.SGD","LU0187121727.USD","SG9999014013.SGD","LU0256863811.USD","HCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651460931","title":"Elevance Beat Earnings Estimates, but the Stock Falls on Medicaid Spending Worries","url":"https://stock-news.laohu8.com/highlight/detail?id=2651460931","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651460931?lang=en_us&edition=fundamental","pubTime":"2026-07-16 01:39","pubTimestamp":1784137140,"startTime":"0","endTime":"0","summary":"Elevance Health stock was down more than 8% in midday trading Wednesday following second-quarter results that beat estimates but were not enough to satisfy investors looking for a stronger recovery.El","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651642464","title":"Elevance Plans to Exit More Medicaid Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2651642464","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651642464?lang=en_us&edition=fundamental","pubTime":"2026-07-15 23:00","pubTimestamp":1784127600,"startTime":"0","endTime":"0","summary":"1100 ET - Elevance Health says it is exiting more Medicaid markets. It recently reached an agreement with Washington, D.C., to leave the city's Medicaid market, and expects to exit more Medicaid markets over the next 12 to 18 months where it doesn't see a path to sustainable growth. The exits are part of Elevance's strategy to improve financial discipline and assess each market based on fit, operational requirements and the ability to generate good return on capital. Health insurers have been raising Medicaid rates to offset rising health costs. Elevance said it had fewer members in the most recent quarter, particularly in its Medicaid and Affordable Care Act plans. Shares drop 10%. Dow Jones NewswiresJuly 15, 2026 11:00 ET Copyright  2026 Dow Jones & Company, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765489.SGD","LU0640476718.USD","LU0878866978.SGD","LU0208291251.USD","LU1023059063.AUD","LU0106261372.USD","LU0122379950.USD","LU2357305700.SGD","LU0251131958.USD","LU1720051017.SGD","LU0289739699.SGD","LU0957791311.USD","SGXZ23171101.USD","LU0742534661.SGD","LU0882574055.USD","LU1489326972.SGD","LU2244417387.USD","LU2430703095.HKD","LU2505996681.GBP","LU0266013472.USD","BK4154","LU1548497426.USD","SG9999003800.SGD","LU1057294990.SGD","LU1670628061.USD","ELV","LU0477156953.USD","LU1720051108.HKD","LU2362541273.HKD","LU0006306889.USD","LU0251142724.SGD","LU0225283273.USD","LU1506573853.SGD","LU1670627923.USD","LU0314104364.USD","SG9999004303.SGD","LU0345770308.USD","LU0048573561.USD","LU0314106906.USD","LU0648001328.SGD","LU2430703178.SGD","LU2237957902.USD","LU0070302665.USD","BK4588","IHF","LU2108987350.USD","LU0130517989.USD","LU0211331839.USD","LU2505996509.AUD","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651610004","title":"Elevance Stock Falls on Medicaid Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2651610004","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651610004?lang=en_us&edition=fundamental","pubTime":"2026-07-15 22:55","pubTimestamp":1784127300,"startTime":"0","endTime":"0","summary":"Skittish investors pushed Elevance shares down, as they focused on worries about its Medicaid business.CEO Gail Boudreaux said the insurer's Medicaid results were roughly what it expected, but the company is leaving the District of Columbia's Medicaid market and plans to exit others over the next year to 18 months. Under questioning from analysts, company officials wouldn't say how extensive those departures will be.Elevance shares were down 10% Wednesday, while competitors including Centene and Molina also slipped. The industry is under pressure from shrinking enrollment in Affordable Care Act plans and Medicaid.Elevance is seeing higher spending in areas including autism therapy, emergency-room use, outpatient surgery and specialty drugs.Elevance's second-quarter earnings beat Wall Street expectations, but its guidance for the full year was raised only modestly. The company reiterated that it expected 2026 to be the \"trough year\" for its Medicaid business's financial performance.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","LU1670627923.USD","LU0106831901.USD","SG9999011175.SGD","LU0098860793.USD","LU2430703251.USD","LU1162221912.USD","LU0058720904.USD","ELV","LU0048573561.USD","LU0971096721.USD","LU0648001328.SGD","LU0882574055.USD","LU2362541273.HKD","BK4504","LU2065170008.USD","IHF","BK4154","IE0034235188.USD","CNC","LU1074936037.SGD","LU2264538146.SGD","LU0314104364.USD","RSPH","PSCH","LU0314106906.USD","LU2237957811.SGD","LU0912757837.SGD","LU1989771016.USD","LU1244550494.USD","LU2347655156.SGD","MOH","SG9999003800.SGD","LU0130518102.USD","SG9999014005.SGD","SG9999014021.USD","LU0557290698.USD","LU0648000940.SGD","KBWB","LU0251131958.USD","LU1670628061.USD","BK4532","LU0795875169.SGD","LU0122379950.USD","LU1668664300.SGD","LU2111349929.HKD","LU1064131342.USD","CNCG","IAI","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651667274","title":"Johnson & Johnson: Expiration of ACA subsidies won’t impact procedure demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2651667274","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651667274?lang=en_us&edition=fundamental","pubTime":"2026-07-15 21:26","pubTimestamp":1784121993,"startTime":"0","endTime":"0","summary":"Does not expect expiration of Affordable Care Act subsidies to materially impact demand for MedTech and procedures. Published first on TheFly – the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnson-expiration-of-aca-subsidies-wont-impact-procedure-demand-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnson-expiration-of-aca-subsidies-wont-impact-procedure-demand-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","IHF","FHLC","HUM","LU2129689514.USD","JNJ","LU2023250330.USD","LU1244550577.SGD","IXJ","LU1066051498.USD","LU2089984988.USD","LU0203347892.USD","LU1674673428.USD","LU0426412945.USD","LU1718418525.SGD","LU1066051811.HKD","ACA","IE0002270589.USD","LU0878866978.SGD","HCA","LU0792757196.USD","RXL","LU2355687059.USD","LU0068578508.USD","LU0433182093.SGD","VHT","SG9999014005.SGD","LU2403377893.USD","XLV","LU0274383776.USD","RSPH","LU0210536198.USD","LU0289739699.SGD","GDOC","BMED","JDOC","LU2505996681.GBP","BK4185","LU0098860793.USD","PJP","IHE","IYH","BK4550","XHS","CURE","LU1280957306.USD","LU1551013425.SGD","FXH","LU2112291526.USD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651468729","title":"iX Biopharma Warrants See Strong Insider Take-Up, Funding U.S. Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2651468729","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651468729?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:08","pubTimestamp":1784117284,"startTime":"0","endTime":"0","summary":"The latest update is out from iX Biopharma Ltd. ( ($SG:42C) ). Singapore-based iX Biopharma Ltd. operates in the biopharmaceutical industry, focusi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ix-biopharma-warrants-see-strong-insider-take-up-funding-u-s-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ix-biopharma-warrants-see-strong-insider-take-up-funding-u-s-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","GSKH","RSPH","SURI","PPH","SG","BK4209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651655484","title":"Celcuity announces FDA approval of Revtorpyk","url":"https://stock-news.laohu8.com/highlight/detail?id=2651655484","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651655484?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:55","pubTimestamp":1784062511,"startTime":"0","endTime":"0","summary":"Celcuity (CELC) announced that the U.S. Food and Drug Administration approved REVTORPYK for the treatment of patients with hormone receptor positiv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celcuity-announces-fda-approval-of-revtorpyk-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celcuity-announces-fda-approval-of-revtorpyk-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4588","IDNA","IBB","PINK","MRNX","BK4139","LFSC","FRTY","MRNY","IYH","GDOC","BK4585","LABU","PSCH","MEDI","SYNB","TECB","BBP","CELC","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105708","title":"HCA Says Florida Medicaid Approval Cushions 2Q","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105708","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105708?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:45","pubTimestamp":1784033100,"startTime":"0","endTime":"0","summary":"A regulatory win in Florida is providing HCA Healthcare with a timely offset to its payer mix pressures. The company recognized approximately $400 million in incremental net benefit from Medicaid Supplemental Payment Programs during the second quarter, the company said. The bulk of that stems from Florida's state-directed payment program, which the Centers for Medicare and Medicaid Services approved during the quarter. The benefit covers the period from Oct. 1, 2024, through June 30, 2026. HCA now expects Medicaid supplemental programs to contribute $300 million to $500 million for full-year 2026, compared with an earlier estimate of a $50 million to $250 million dragThis article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors. Dow Jones NewswiresJuly 14, 2026 08:45 ET Copyright  2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0980610538.SGD","LU0708994859.HKD","BK4185","BK4504","LU1267930573.SGD","LU0882574055.USD","LU1150488218.USD","LU0187121727.USD","LU0310799852.SGD","SG9999014013.SGD","BK4585","LU0203345920.USD","LU1201861249.SGD","RSPH","LU0029864427.USD","LU1267930490.SGD","LU0211328371.USD","HCA","LU2355687059.USD","SG9999014005.SGD","LU0128525929.USD","LU0868494617.USD","BK4588","LU0068578508.USD","LU0203347892.USD","LU1119994496.HKD","LU0985489474.SGD","LU1084165304.USD","LU0878866978.SGD","LU0211327993.USD","SG9999014021.USD","LU1150488135.SGD","SG9999014039.USD","LU1261432733.SGD","LU0648001328.SGD","IE00B3S45H60.SGD","LU1489326972.SGD","LU2244417387.USD","LU0130102774.USD","LU0310800379.SGD","IHF","IE00B775SV38.USD","LU0433182093.SGD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105407","title":"Caris Life Sciences expands prostate cancer offering with PTEN IHC testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105407","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105407?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:35","pubTimestamp":1784032510,"startTime":"0","endTime":"0","summary":"Caris Life Sciences (CAI) will offer in-house PTEN immunohistochemistry, or IHC, testing following the recent FDA approval of a biomarker-guided th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-expands-prostate-cancer-offering-with-pten-ihc-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-expands-prostate-cancer-offering-with-pten-ihc-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IHC","LABU","MEDI","BK4104","IDNA","PTEN","MRNX","PINK","PSCH","RSPH","SYNB","LFSC","MRNY","BK4585","BMED","BK4588","BK4092","BK4162","CAI","BK4139","FRTY","GDOC","TECB","IBB","BBP","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140004210","title":"Shanxi's Shuozhou City Enhances Safety Oversight of Cold Chain Medical Equipment","url":"https://stock-news.laohu8.com/highlight/detail?id=1140004210","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140004210?lang=en_us&edition=fundamental","pubTime":"2026-07-14 14:50","pubTimestamp":1784011838,"startTime":"0","endTime":"0","summary":"Authorities in Shuozhou City, Shanxi Province, have launched a targeted inspection initiative focusing on the management of cold chain systems within medical institutions and businesses involved in...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","HART","BK1583","LGHT","RSPH","09996","BK1574","PTH","MEDX","BK1100","159883","MDEV","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651612476","title":"Nexalis Therapeutics Options Expire Unexercised, Streamlining Capital Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2651612476","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651612476?lang=en_us&edition=fundamental","pubTime":"2026-07-14 13:27","pubTimestamp":1784006857,"startTime":"0","endTime":"0","summary":"InhaleRx Limited ( ($AU:NX1) ) just unveiled an announcement. Nexalis Therapeutics Ltd, an ASX-listed biotechnology company trading under the ticke...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-options-expire-unexercised-streamlining-capital-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-options-expire-unexercised-streamlining-capital-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BBP","IBB","LENZ","RSPH","SYNB","BK4139","XT","BK4007","BK4585","FHLC","DARP","FWD","BK4539","AGNG","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651247371","title":"Nexalis Therapeutics Issues Over 4.1 Million Unquoted Performance Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2651247371","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651247371?lang=en_us&edition=fundamental","pubTime":"2026-07-14 13:27","pubTimestamp":1784006835,"startTime":"0","endTime":"0","summary":"InhaleRx Limited ( ($AU:NX1) ) just unveiled an update. Nexalis Therapeutics Ltd is an Australian-listed biotechnology company focused on developin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-issues-over-4-1-million-unquoted-performance-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-issues-over-4-1-million-unquoted-performance-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BBP","IBB","LENZ","RSPH","SYNB","BK4139","XT","BK4007","BK4585","FHLC","DARP","FWD","BK4539","AGNG","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651140172","title":"Aroa Biosurgery Welcomes CMS Plan to Keep Outpatient Skin Substitute Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2651140172","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651140172?lang=en_us&edition=fundamental","pubTime":"2026-07-14 08:08","pubTimestamp":1783987683,"startTime":"0","endTime":"0","summary":"Aroa Biosurgery Ltd ( ($AU:ARX) ) has shared an announcement. The United States Centers for Medicare & Medicaid Services has proposed keeping the c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aroa-biosurgery-welcomes-cms-plan-to-keep-outpatient-skin-substitute-rates?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aroa-biosurgery-welcomes-cms-plan-to-keep-outpatient-skin-substitute-rates?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2346227817.USD","LU0738911758.USD","LU0553294199.USD","RSPH","BK4588","LU0949170772.SGD","LU1894683264.USD","LU0545039389.USD","BK4208","LU2637428348.USD","CMS","LU1894683348.USD","BK4585","LU0661504455.SGD","LU1003077747.HKD","LU2500361329.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651422771","title":"BioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2651422771","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651422771?lang=en_us&edition=fundamental","pubTime":"2026-07-14 06:08","pubTimestamp":1783980525,"startTime":"0","endTime":"0","summary":"BioArctic AB Class B ( ($SE:BIOA.B) ) has shared an update. BioArctic’s partner Eisai has secured U.S. FDA approval for Leqembi Iqlik, a once-weekl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bioarctics-partner-eisai-wins-fda-nod-for-at-home-leqembi-injection-in-early-alzheimers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bioarctics-partner-eisai-wins-fda-nod-for-at-home-leqembi-injection-in-early-alzheimers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999002679.SGD","MRNX","IBB","SG9999014484.SGD","LU0251143029.SGD","IYH","LU2152927971.USD","HBCP","SE","RSPH","SG9999014492.USD","GDOC","LABU","LU1861220207.SGD","BK4554","SG9999002620.SGD","BK4535","LU0823039010.USD","LFSC","LU2360107671.USD","LU2125910849.SGD","PINK","LU0499858438.USD","LU0516423091.SGD","LU0532188223.SGD","BBP","BMED","IE0031814969.USD","FDNI","FRTY","LU2065170008.USD","BK4585","LU0441851309.USD","BK4220","LU0516423174.USD","BK4588","PSCH","SG9999002414.USD","SG9999013478.USD","BK4503","TECB","SG9999002406.SGD","SYNB","LU0589944569.HKD","MEDI","BK4211","LU2065171402.SGD","MRNY","LU0516422366.SGD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}